Akebia Therapeutics (AKBA) FY Conference August 13, 2025 01:30 PM ET Speaker0Hi. Good afternoon, everyone. My name is Edward Nash, senior biotechnology analyst here at Canaccord Genuity and Equity Research. I have the pleasure of being with me today, Akebia Therapeutics. From Akebia, we have John Butler who is the president and chief executive officer.John, thank you so much for joining us.Speaker1Edward, thanks for the invitation.Speaker0And we do have Eric Ostralski, who's the chief financial officer out ...